Comparative metabolism and disposition of ethylene glycol monomethyl ether and propylene glycol monomethyl ether in male rats

• Published in: Toxicology and applied pharmacology Vol. 67; no. 2; p. 229
• Main Authors: Miller, R R, Hermann, E A, Langvardt, P W, McKenna, M J, Schwetz, B A
• Format: Journal Article
• Language: English
• Published: United States 01.02.1983
• Subjects: Animals; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Ethylene Glycols - metabolism; Ethylene Glycols - urine; Male; Propylene Glycols - metabolism; Propylene Glycols - urine; Rats; Rats, Inbred F344; Solvents; Tissue Distribution
• ISSN: 0041-008X
• DOI: 10.1016/0041-008x(83)90229-6

Male Fischer 344 rats were given a single po dose of approximately 1 or 8.7 mmol/kg of [14C]EGME (ethylene glycol monomethyl ether) or [14C]PGME (propylene glycol monomethyl ether). After dosing, expired air, excreta, and tissues were analyzed for 14C; metabolites in urine were isolated and identified. There were pronounced differences in the metabolism and disposition of [14C]EGME and [14C]PGME. Approximately 50 to 60% of the administered 14C was excreted in urine, and about 12% was eliminated as 14CO2 within 48 hr after a single po dose of [14C]EGME. For PGME, only 10 to 20% of the administered 14C was excreted in urine, while 50 to 60% was eliminated as 14CO2 within 48 hr. Methoxyacetic acid was identified as the primary urinary metabolite of EGME, accounting for 80 to 90% of the total 14C in urine. PGME, propylene glycol(1,2-propanediol), and the sulfate and glucuronide conjugates of PGME were identified in urine of rats given PGME. Since methoxyacetic acid causes the same spectrum of toxicity as EGME in male rats, it is likely that the adverse effects of EGME are the result of its in vivo bioactivation to methoxyacetic acid. Hence, differences in routes of metabolism and types of metabolites appear to be the underlying basis for the remarkably different toxicologic properties of EGME and PGME, respectively.